John Edwin Nestler
#141,988
Most Influential Person Now
John Edwin Nestler's AcademicInfluence.com Rankings
John Edwin Nestlerphilosophy Degrees
Philosophy
#7447
World Rank
#10664
Historical Rank
Logic
#4496
World Rank
#5801
Historical Rank
John Edwin Nestlerbiology Degrees
Biology
#10113
World Rank
#13410
Historical Rank
Cell Biology
#466
World Rank
#477
Historical Rank
Molecular Biology
#1440
World Rank
#1467
Historical Rank
Biochemistry
#1579
World Rank
#1710
Historical Rank
Download Badge
Philosophy Biology
Why Is John Edwin Nestler Influential?
(Suggest an Edit or Addition)John Edwin Nestler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. (1986) (1543)
- Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. (2007) (922)
- Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. (2005) (828)
- Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. (1998) (782)
- Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. (1996) (742)
- A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. (1991) (742)
- Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. (1998) (625)
- Effects of metformin on early pregnancy loss in the polycystic ovary syndrome (2002) (504)
- Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. (1988) (441)
- Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. (1997) (361)
- Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. (2001) (348)
- Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. (1989) (343)
- Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. (2007) (336)
- Metformin for the treatment of the polycystic ovary syndrome. (2008) (323)
- Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome (1999) (315)
- Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. (2005) (295)
- Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. (2004) (294)
- Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2015) (286)
- Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999) (247)
- Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. (2002) (229)
- Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? (1993) (202)
- Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. (2001) (199)
- A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. (2003) (190)
- Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. (2010) (182)
- Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. (1997) (174)
- The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. (1987) (170)
- Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. (2002) (161)
- The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life (1999) (156)
- Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? (2006) (154)
- Insulin regulation of human ovarian androgens. (1997) (150)
- Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. (2006) (145)
- Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. (2001) (144)
- Insulin Sensitizers for Polycystic Ovary Syndrome (2003) (140)
- Insulin as an effector of human ovarian and adrenal steroid metabolism. (1991) (138)
- 17α-Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss1 (1997) (133)
- Sex hormone-binding globulin and type 2 diabetes mellitus (2012) (132)
- Effect of macronutrient composition on postprandial peptide YY levels. (2007) (130)
- Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. (1989) (124)
- Cardiometabolic aspects of the polycystic ovary syndrome. (2012) (114)
- Dehydroepiandrosterone: the “missing link” between hyperinsulinemia and atherosclerosis? (1992) (112)
- The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. (2000) (111)
- Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. (2008) (106)
- The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome (1989) (103)
- Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I. (1987) (101)
- The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. (2006) (101)
- Insulin inhibits adrenal 17,20-lyase activity in man. (1992) (99)
- Lack of effect of dehydroepiandrosterone in obese men. (1990) (99)
- American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. (2005) (99)
- In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. (1991) (96)
- Clomiphene citrate, metformin or both as first‐step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head‐to‐head randomized controlled studies and meta‐analysis (2009) (95)
- Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials (2016) (93)
- Genetic Covariation between Serum γ-Glutamyltransferase Activity and Cardiovascular Risk Factors (2002) (85)
- Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. (2004) (84)
- Reflections on inositol(s) for PCOS therapy: steps toward success (2015) (81)
- Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. (2008) (81)
- Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. (2004) (81)
- Insulin-lowering drugs in polycystic ovary syndrome. (2001) (81)
- Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. (2008) (80)
- Dehydroepiandrosterone Inhibits Human Platelet Aggregation in Vitro and in Vivo a (1995) (77)
- Androgen excess disorders in women (2007) (76)
- Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials (2017) (75)
- Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome. (2010) (74)
- The metabolic syndrome in polycystic ovary syndrome (2006) (74)
- Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome (2008) (73)
- Predictors of pregnancy in women with polycystic ovary syndrome. (2009) (72)
- Dermatology of androgen-related disorders. (2006) (69)
- Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. (1994) (68)
- Sleep-Associated Fall in Glucose Disposal and Hepatic Glucose Output in Normal Humans: Putative Signaling Mechanism Linking Peripheral and Hepatic Events (1989) (67)
- Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. (2011) (65)
- Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective. (2008) (65)
- 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. (1997) (63)
- Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled Trial. (2016) (62)
- Lean Women With Polycystic Ovary Syndrome Respond to Insulin Reduction With Decreases in Ovarian P450c17 alpha Activity and Serum Androgens (1998) (62)
- Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts. (1990) (61)
- Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels (2010) (57)
- Insulin and insulin-like growth factor-I stimulate the 3 beta-hydroxysteroid dehydrogenase activity of human placental cytotrophoblasts. (1989) (57)
- Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men. (1996) (56)
- Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts. (1993) (56)
- Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. (2002) (55)
- Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis. (2007) (55)
- The metabolic syndrome in polycystic ovary syndrome. (2007) (53)
- Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers. (2006) (53)
- The insulin-like growth factor, somatomedin-C, modulates low density lipoprotein metabolism by swine granulosa cells. (1987) (52)
- Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. (1990) (51)
- Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men. (1995) (51)
- Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement. (2002) (50)
- Fertility in polycystic ovary syndrome. (2006) (49)
- Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. (1995) (48)
- Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast. (1992) (48)
- Inositols in Polycystic Ovary Syndrome: An Overview on the Advances (2020) (47)
- Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. (1994) (47)
- Insulin mediators are the signal transduction system responsible for insulin's actions on human placental steroidogenesis. (1991) (47)
- Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. (1993) (46)
- Interleukin-1 is induced in the human placenta by endotoxin and isolation procedures for trophoblasts. (1992) (44)
- Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. (1994) (44)
- Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome (2009) (44)
- Insulin regulates low density lipoprotein metabolism by swine granulosa cells. (1986) (43)
- Uptake of gold- and [3H]cholesteryl linoleate-labeled human low density lipoprotein by cultured rat granulosa cells: cellular mechanisms involved in lipoprotein metabolism and their importance to steroidogenesis (1985) (43)
- The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. (1993) (42)
- Endometrial Shedding Effect on Conception and Live Birth in Women With Polycystic Ovary Syndrome (2012) (42)
- Inositols: From Established Knowledge to Novel Approaches (2021) (40)
- Metabolism and actions of dehydroepiandrosterone in humans (1991) (40)
- Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. (2011) (39)
- Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome. (2006) (38)
- Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond (2020) (38)
- Regulation of Human Dehydroepiandrosterone Metabolism by Insulin a (1995) (37)
- Metabolic syndrome in women with polycystic ovary syndrome. (2006) (37)
- Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome? (2006) (36)
- Metabolism of high density lipoproteins reconstituted with [3H]cholesteryl ester and [14C]cholesterol in the rat, with special reference to the ovary. (1985) (36)
- Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. (1987) (36)
- Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. (2000) (36)
- 7 Diabetes and adrenal disease (1992) (34)
- Regulation of the aromatase activity of human placental cytotrophoblasts by insulin, insulin-like growth factor-I, and -II (1993) (33)
- Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART) (2020) (32)
- Polycystic ovary syndrome: a disorder for the generalist. (1998) (32)
- Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? (2004) (32)
- Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects. (2002) (31)
- Absorption Characteristic of Breakfast Determines Insulin Sensitivity and Carbohydrate Tolerance for Lunch (1988) (31)
- Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome. (2010) (28)
- Sites of inhibition of steroidogenesis by activation of protein kinase-C in swine ovarian (granulosa) cells. (1993) (28)
- Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. (2008) (28)
- Dehydroepiandrosterone (DHEA) and aging (1995) (26)
- Diabetes and adrenal disease. (1992) (24)
- Inositolphosphoglycans (IPGs) as Mediators of Insulin's Steroidogenic Actions (1998) (24)
- Activation of the LH receptor up regulates the type 2 adiponectin receptor in human granulosa cells (2013) (24)
- Hemochromatosis and pruritus. (1983) (23)
- Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. (2014) (22)
- Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome. (2010) (22)
- Accelerated decline in hepatic glucose production during fasting in normal women compared with men. (1989) (22)
- Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome. (2016) (22)
- The pathophysiology of miscarriage in women with polycystic ovary syndrome. Review and proposed hypothesis of mechanisms involved. (2004) (22)
- Stimulation of rat ovarian cell steroidogenesis by high density lipoproteins modified with tetranitromethane. (1985) (21)
- The polycystic ovary syndrome: treatment with insulin sensitizing agents (1999) (21)
- Advances in understanding the regulation and biologic actions of dehydroepiandrosterone (1996) (21)
- Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. (2005) (21)
- Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future (2015) (21)
- Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus. (2004) (20)
- Insulin resistance and the polycystic ovary syndrome: recent advances (2000) (19)
- Morning Insulin Requirements: Critique of Dawn and Meal Phenomena (1989) (18)
- A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. (2012) (17)
- Failure of a Midnocturnal Insulin Infusion to Suppress the Increased Insulin Need for Breakfast in Insulin-dependent Diabetic Patients (1984) (16)
- Inositol(s) from Bench to Bedside in Endocrinology and Gynecology (2017) (16)
- Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. (2011) (16)
- Reduced Insulin Clearance in Normal Subjects Due To Extreme Hyperinsulinemia (1988) (15)
- Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome (2002) (14)
- Leptin secretory burst mass correlates with body mass index and insulin in normal women but not in women with polycystic ovary syndrome. (2007) (14)
- Effects of extreme hyperinsulinaemia on serum levels of trace metals, trace metal binding proteins, and electrolytes in normal females. (1987) (14)
- Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women. (2011) (14)
- Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. (2007) (13)
- Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. (2008) (13)
- Decreases in Ovarian Cytochrome P450c17 alpha Activity and Serum Free Testosterone After Reduction of Insulin Secretion in Polycystic Ovary Syndrome (1997) (13)
- Insulin Resistance Effects on Sex Hormones and Ovulation in the Polycystic Ovary Syndrome (1999) (13)
- Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. (2008) (12)
- Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial. (2008) (12)
- Insulin sensitivity of splanchnic and peripheral adipose tissue in vivo in morbidly obese man. (1993) (12)
- INTRODUCTION.: DHEA: A Coming of Age (1995) (12)
- Altering Hirsutism Through Ovulation Induction in Women With Polycystic Ovary Syndrome (2012) (12)
- Polycystic Ovary Syndrome. (2016) (11)
- Metformin and the polycystic ovary syndrome. (2001) (11)
- Inhibition of cardiac allograft atherosclerosis by dehydroepiandrosterone (1990) (11)
- Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial. (2010) (10)
- Dehydroepiandrosterone in vivoand in vitroinhibits platelet aggregation (1991) (10)
- Body mass index and intercourse compliance. (2010) (10)
- Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity (2005) (9)
- Dehydroepiandrosterone: Fountain of Youth or Snake Oil? (1997) (9)
- Nitrendipine treatment in women with polycystic ovarian syndrome: evidence for a lack of effects of calcium channel blockers on insulin, androgens, and sex hormone-binding globulin. (1995) (9)
- Metformin in the Treatment of Infertility in PCOS: An Alternative Perspective (2008) (9)
- Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome. (2016) (9)
- Prolonged insulin resistance following insulin-induced hypoglycaemia (1987) (9)
- The role of variants regulating metformin transport and action in women with polycystic ovary syndrome. (2016) (9)
- D-chiro-inositol (INS-1) enhances ovulatory rate in hyperandrogenemic, oligomenorrheic women with the polycystic ovary syndrome. (2001) (8)
- Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2016) (8)
- Biosynthesis and turnover of a 34-kDa protein growth factor in human cytotrophoblasts. (1988) (8)
- REGULATION OF DEHYDROEPIANDROSTERONE METABOLISM BY INSULIN, AND METABOLIC EFFECTS OF DEHYDROEPIANDROSTERONE IN MAN (1990) (8)
- Insulin resistance syndrome and polycystic ovary syndrome. (2003) (7)
- Feasibility of Delivering an Avatar-Facilitated Life Review Intervention for Patients with Cancer. (2020) (7)
- Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man. (1990) (7)
- Insulin sensitizers in adolescents with polycystic ovary syndrome. (2017) (7)
- A Paradox: the roles of inositolphosphoglycans in mediating insulin sensitivity and hyperandrogenism in the polycystic ovary syndrome. (2004) (6)
- Impaired Glucose Tolerance in Polycystic Ovary Syndrome (2010) (6)
- Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome. (2007) (5)
- Insulin and adrenal androgens (1994) (4)
- Errors in the Measurement of Plasma Free Testosterone—Author’s Response 1 (1997) (4)
- American Association of Clinical Endocrinologists (aace) Reproductive Medicine Committee Position Statement on Bioidentical Hormones (2007) (4)
- Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome? (2006) (4)
- Abstract 24021: Sacubitril/Valsartan Attenuates Fibrosis and Improves Left Ventricular Function in a Rabbit Model of HFrEF (2017) (3)
- Myo-inositol: with or without. (2015) (3)
- Sex hormone-binding globulin and risk of type 2 diabetes. (2009) (3)
- Are There Sex-Specific Effects of Insulin on Human Dehydroepiandrosterone Metabolism? (1995) (3)
- DHEA A Coming of Age (2006) (3)
- Immunoglobulin D multiple myeloma with thrombocytosis. (1981) (3)
- Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome (2016) (2)
- Insulin Resistance and Polycystic Ovarian Syndrome (2007) (2)
- Improv to improve medical student communication (2021) (2)
- Relation of Adrenal Androgen to Insulin Levels (1993) (1)
- Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (1)
- Use of Insulin Sensitizers in the Polycystic Ovary Syndrome (2006) (1)
- Insulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome (2007) (1)
- Comprar Insulin Resistance and Polycystic Ovarian Syndrome · Pathogenesis, Evaluation, and Treatment | Diamanti-Kandarakis, Evanthia | 9781588297631 | Springer (2007) (1)
- Stimulation of androgen production by insulin-like growth factor I. (1986) (1)
- Abstract 16515: Reperfusion Therapy With Sacubitril/Valsartan Attenuates Infarct Size and Preserves Left Ventricular Function in a Rabbit Model of Myocardial Infarction (2017) (1)
- INTRODUCTION (1995) (1)
- O-081 The effect of DHEA replacement on the endocrine and lipid profiles of perimenopausal women (1997) (1)
- Evaluation and treatment of the hirsute woman. (1989) (1)
- Lack of effect of insulin or insulin-like growth factor I on the steroid sulfatase activity of human placental cytotrophoblasts. (1989) (1)
- The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome (2009) (1)
- PSMC 5 , a 19 S Proteasomal ATPase , Regulates Cocaine Action in the Nucleus Accumbens Citation (2015) (0)
- Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation (1993) (0)
- The Effect of PCOS on Fertility and Pregnancy (2009) (0)
- Insulin Resistance and Hyperinsulinism in the Polycystic Ovary Syndrome (2006) (0)
- Materials and Methods We performed a secondary data analysis of serum liver and renal function in subjects participating in the Reproductive Medicine Network (2011) (0)
- Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (0)
- Predictors of weight loss in obese women with polycystic ovary syndrome as compared to obese normal women (2010) (0)
- Racial difference in insulin resistance between African-American and caucasian women with polycystic ovary syndrome (2011) (0)
- EFFECTS OF METFORMIN ON SPONTANEOUS AND CLOMIPHENE-INDUCED OVULATION IN THE POLYCYSTIC OVARY SYNDROME (1998) (0)
- Editorial commentary: Reproductive endocrinology (2002) (0)
- Dietary dehydroepiandrosterone inhibits graft arteriosclerosis in rabbit heterotopic cardiac allografts (1993) (0)
- The Androgen Excess Society guidelines on glucose intolerance in the polycystic ovary syndrome: what do they mean and what should we do? (2008) (0)
- SAT-240 Type B Insulin Resistance Resulting in Hyperthecosis in a Postmenopausal Woman (2019) (0)
- Chapter 24 / Insulin Resistance and Hyperinsulinism 273 273 (0)
- A new peptide growth factor from human placenta: Biochemical & immunological characterization (1986) (0)
- Intercourse Compliance, Ovulation and Treatment Success in the NICHD-Reproductive Medicine Network’s “Pregnancy in Polycystic Ovary Syndrome” (PPCOS) Trial (2010) (0)
- The Polycystic Ovary Syndrome and Insulin Resistance (2001) (0)
- Thyroid scanning or fine-needle biopsy. (1985) (0)
- Hyperinsulinaemia and trace metals (1988) (0)
- Should PCOS Be Treated With Insulin Sensitizers or Oral Contraceptives (2006) (0)
- Should we consider treating patients with refractory PCOS for infertility (2000) (0)
- Medication Adherence and Treatment Success in the NICHD-Reproductive Medicine Network’s “Pregnancy in Polycystic Ovary Syndrome” (PPCOS) Trial (2008) (0)
- Letter to the editorReply of the author (2002) (0)
- Grand rounds: idiopathic hemochromatosis. (1982) (0)
- PLASMA VITAMIN D BINDING PROTEIN: PLASMA SCAVENGER FUNCTION AND ORIGIN OF CELL-SURFACE DBP. (1988) (0)
- Corrigendum to “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology” (2017) (0)
- Failure of a short-term (61 hour) fast to enhance the growth hormone response to luteinizing hormone-releasing hormone in normal man (1991) (0)
- Inositol ( s ) fromBench to Bedside in Endocrinology andGynecology (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John Edwin Nestler?
John Edwin Nestler is affiliated with the following schools:
